Elutia (ELUT) Return on Assets (2020 - 2026)

Elutia (ELUT) posted Return on Assets of 0.01% for Q1 2026, down 18.85% sequentially from 0.01% in Q4 2025, and up 1.0% YoY from 0.01% in Q1 2025.

Elutia (ELUT) Return on Assets (2020 - 2026) Analysis & Trends

Elutia has reported Return on Assets for 7 years, with the latest figure at 0.01% in Q1 2026.

Quarterly Return on Assets rose 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, up 2.0% from the prior year.
Return on Assets fell to 0.01% in Q1 2026 per ELUT's latest filing, from 0.01% in the prior quarter.
Over five years, Return on Assets peaked at 0.01% in Q4 2025 and troughed at 0.01% in Q2 2022.
A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
The sharpest annual moves came in 2024 and 2025: Return on Assets decreased 1 bps in 2024, then rose 2 bps in 2025.
Over 5 years, Return on Assets stood at 0.0% in 2022, then jumped by 130 bps to 0.0% in 2023, then sank by 802 bps to 0.01% in 2024, then soared by 363 bps to 0.01% in 2025, then retreated by 19 bps to 0.01% in 2026.
According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.01%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.00%
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	0.00%
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.00%
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	0.00%
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	0.00%
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	0.00%
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	0.00%
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	0.00%
10	Elutia	39.87 Mn	19.98 Mn	1.45 Mn	0.01%

Download Data